Researchers, clinicians and patients & families are to support a workshop in La Jolla, San Diego (March 29th-31st) for those focused on finding treatments on… Read More »A Peripherin 2 (Prph2) retinal disease workshop is scheduled with international researchers, clinicians and patients, supported by Foundation Fighting Blindness
Researchers have announced recruitment of the first patient in a clinical trial of a an experimental AAV gene therapy for the treatment of X-linked retinitis… Read More »A phase I/II study has announced the recruitment of the first patient for a novel AAV-RPGR treatment for X-linked retinitis pigmentosa.
Researchers at the Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, have reported that outcome measures for future clinical trials should include evaluations… Read More »Outcome measures for future trials for autosomal dominant vitelliform macular dystrophy caused by BEST1 mutations.
Researchers at the UCL Institute of Ophthalmology, London and Moorfields Eye Hospital NHS Foundation Trust has reported a novel history of RP2 mutations arising from… Read More »A natural history of XLRP from RP2 mutations aim to facilitate trial endpoints for future clinical studies.
An interim analysis from a Phase II study for a novel peptide (THR-149) is aimed to prevent the induction of retinal vascular permeability, neurodegeneration and… Read More »Phase II data on a novel peptide candidate – plasma kallikrein (PKal) (THR-149) – for treatment of diabetic macular edema (DME)
Despite positive initial clinical data from an ongoing open label Phase I/II “BRILLIANCE” study, named EDIT-101, a CRISPR-based experimental treatment for the treatment of Leber… Read More »Pausing of CRISPR gene editing therapy for LCA CEP290-related retinal degeneration from >15 patients
Researchers analysing data from the UK Biobank have reported that poorer visual acuity was associated with depressive symptoms, measured by Patient Health Questionnaire (PHQ) scores… Read More »Research from the UK Biobank Study reports data associating visual health, depression and altered brain neurobiology
Researchers at the Institute of Applied Ophthalmobiology (IOBA), University of Valladolid, Spain, has reported results on the use of hair cortisol concentrations (HCC), measuring chronic… Read More »EURETINA Hamburg 2022: Spanish researchers report that hair cortisol level may be used as a molecular biomarker in retinitis pigmentosa patients
Researchers at the Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, and the University of Coimbra, Portugal, has reported phenotypic differences… Read More »Clinical researchers on rare variants of the CFH gene has reported significant burden of disease among AMD patients
Researchers in the Diabetic Retinopathy Clinical Research (DRCR) Retina Network has reported that the treatment of moderate vision loss due to diabetic macular edema found… Read More »Aflibercept monotherapy or “bevacizumab first” for diabetic macular edema assessed the evidence on visual outcomes and costs to the healthcare system.